Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative inhalation of indocyanine green to detect air leaks during VATS lung resection
ChiCTR2400080627Phase 2Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of indocyanine green in pulmonary diseases, air-leak syndrome and alveolopleural fistula (APF) (2 arms), sponsored by Peking University People's Hospital. Primary endpoints: Postoperative air leak rate and Number and size of intraoperatively detected air leaks. Started Feb 2024; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
pulmonary diseasesair-leak syndromealveolopleural fistula (APF)
Beyond the preview
Go deeper on ChiCTR2400080627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080627.